IMMU-26. TLR7 ACTIVATION IS ESSENTIAL FOR NK CELLS TO ELIMINATE GLIOMA TUMORS

Our laboratory focuses on understanding anti-glioma immune responses and uses this information to develop new immunotherapies. Endogenous anti-glioma immune responses fail to control the disease due to the development of immune inhibitory mechanisms by glioma tumors. We developed an immune- and gene...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Shah, Diana, Kadiyala, Padma, Kamran, Neha, Baker, Gregory J, Doherty, Robert, Zamler, Dan, Nuñez, Gabriel, Castro, Maria G, Lowenstein, Pedro R
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692501/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.484
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares